越来越多的研究表明细胞免疫异常参与了血小板破坏机制。
However, humoral mechanisms cannot account for all observations made in this disorder, and it is increasingly evident that cellular mechanisms contribute to platelet destruction.
在慢性ITP患者中，免疫系统在破坏血小板，而病人的骨髓增生往往是无法弥补这一损失。
In patients with chronic ITP, the immune system is believed to destroy platelets and the patient's bone marrow is often unable to compensate for this loss.
结论：abo不合的干细胞移植患者输血，应使用不被患者血清凝集素破坏的红细胞和不带有其它血清凝集素的血小板浓缩液。
Conclusion: RBCs and platelet with me not destroyed by the recipients' serum agglutinin were required for patients undergoing ABO incompatible allogenic stem cell transplantation.
应用推荐